Evidence map›Paper›PMID 37601593›Full record

ArticleRSC advances2023

TiN/Ti

Ke Wang, Qidong Liu, Zhenhong Wang, Yufeng Song, Haiming Huang, Ni Fan, Yujie Wang, Bin Zhang

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ke WangInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Qidong LiuInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Zhenhong WangInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Yufeng SongInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Haiming HuangInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Ni FanShenzhen Han's Robot Co., Ltd. 518100 China.
Yujie WangInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.
Bin ZhangInstitute of Translational Medicine, First Affiliated Hospital (Shenzhen Second People's Hospital), Health Science Center, College of Electronics and Information Engineering, Shenzhen University 518060 China yujiewang@email.szu.edu.cn wenwubin09@163.com.ORCID https://orcid.org/0000-0002-2112-2555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the new nanomaterials, TiN/Ti

Identifiers

PMID37601593
PMCPMC10433717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.